Healthcare provider profile · identity verified

Angela Mccarthy Lucas, MD

Family Practice · BRANDON, FL · NPI 1336458298

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	464	169
Lisinopril	Lisinopril	342	113
Albuterol Sulfate Hfa	Albuterol Sulfate	305	116
Rosuvastatin Calcium	Rosuvastatin Calcium	296	113
Amlodipine Besylate	Amlodipine Besylate	294	102
Gabapentin	Gabapentin	271	97
Tizanidine Hcl	Tizanidine Hcl	238	103
Diclofenac Sodium	Diclofenac Sodium	222	147
Fluticasone Propionate	Fluticasone Propionate	215	98
Alendronate Sodium	Alendronate Sodium	211	48
Trazodone Hcl	Trazodone Hcl	189	64
Losartan Potassium	Losartan Potassium	188	69
Pantoprazole Sodium	Pantoprazole Sodium	183	89
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	173	59
Metformin Hcl	Metformin Hcl	167	58
Levothyroxine Sodium	Levothyroxine Sodium	157	58
Montelukast Sodium	Montelukast Sodium	157	59
Hydrochlorothiazide	Hydrochlorothiazide	144	56
Tamsulosin Hcl	Tamsulosin Hcl	130	50
Glipizide	Glipizide	125	38
Meloxicam	Meloxicam	118	48
Furosemide	Furosemide	116	43
Omeprazole	Omeprazole	110	51
Azithromycin	Azithromycin	105	85
Simvastatin	Simvastatin	104	31
Metoprolol Succinate	Metoprolol Succinate	97	32
Metformin Hcl Er	Metformin Hcl	96	41
Prednisone	Prednisone	91	47
Famotidine	Famotidine	90	41
Baclofen	Baclofen	89	30
Doxycycline Monohydrate	Doxycycline Monohydrate	88	63
Ibuprofen	Ibuprofen	88	37
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	84	64
Carvedilol	Carvedilol	84	29
Potassium Chloride	Potassium Chloride	83	32
Duloxetine Hcl	Duloxetine Hcl	77	32
Hydroxyzine Hcl	Hydroxyzine Hcl	74	40
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	24
Vitamin D2	Ergocalciferol (Vitamin D2)	73	39
Methylprednisolone	Methylprednisolone	65	56
Clopidogrel	Clopidogrel Bisulfate	64	25
Oxybutynin Chloride Er	Oxybutynin Chloride	63	25
Pregabalin	Pregabalin	63	16
Triamcinolone Acetonide	Triamcinolone Acetonide	59	45
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	16
Metoprolol Tartrate	Metoprolol Tartrate	58	25
Pioglitazone Hcl	Pioglitazone Hcl	51	17
Eliquis	Apixaban	50	17
Allopurinol	Allopurinol	47	14
Sertraline Hcl	Sertraline Hcl	44	19
Sucralfate	Sucralfate	44	16
Buspirone Hcl	Buspirone Hcl	43	16
Hydralazine Hcl	Hydralazine Hcl	43	22
Sildenafil Citrate	Sildenafil Citrate	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	16
Ozempic	Semaglutide	40	18
Meclizine Hcl	Meclizine Hcl	39	19
Tramadol Hcl	Tramadol Hcl	39	16
Escitalopram Oxalate	Escitalopram Oxalate	38	14
Pravastatin Sodium	Pravastatin Sodium	38	13
Nifedipine Er	Nifedipine	35	11
Bupropion Xl	Bupropion Hcl	34	12
Ketoconazole	Ketoconazole	34	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	31
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Alprazolam	Alprazolam	33	11
Finasteride	Finasteride	33	11
Ondansetron Odt	Ondansetron	33	24
Fluconazole	Fluconazole	32	21
Citalopram Hbr	Citalopram Hydrobromide	31	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	13
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Naproxen	Naproxen	30	17
Acyclovir	Acyclovir	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Atenolol	Atenolol	27	suppressed
Latanoprost	Latanoprost	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Nystatin	Nystatin	26	13
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Spironolactone	Spironolactone	25	suppressed
Bumetanide	Bumetanide	24	12
Glipizide Er	Glipizide	22	suppressed
Jardiance	Empagliflozin	22	11
Xarelto	Rivaroxaban	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	11
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Topiramate	Topiramate	20	11
Divalproex Sodium	Divalproex Sodium	19	suppressed
Mirtazapine	Mirtazapine	19	11
Warfarin Sodium	Warfarin Sodium	19	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	18	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	17	suppressed
Levofloxacin	Levofloxacin	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	14	suppressed
Folic Acid	Folic Acid	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	13	suppressed
Valsartan	Valsartan	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lactulose	Lactulose	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error